Cargando…

Paradoxical effects of tumour necrosis factor-α in adjuvant-induced arthritis

Anti-tumour necrosis factor (TNF)α therapy is highly effective in rheumatoid arthritis and it is surprising, therefore, that a recent study showed that intraperitoneal administration of recombinant TNFα reduced the severity of adjuvant-induced arthritis and decreased IFNγ expression in cultured drai...

Descripción completa

Detalles Bibliográficos
Autor principal:	Williams, Richard O
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483450/ https://www.ncbi.nlm.nih.gov/pubmed/18564403 http://dx.doi.org/10.1186/ar2430

Ejemplares similares

Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
por: Kim, Eugene Y, et al.
Publicado: (2008)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
por: Tse, Brian W. C., et al.
Publicado: (2012)

Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa
por: Soto Lopes, Marien Siqueira, et al.
Publicado: (2013)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Tumour necrosis factor blockade and the risk of osteoporosis: back to the future
por: Sambrook, Philip
Publicado: (2007)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
por: Bonetti, N. R., et al.
Publicado: (2019)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Effect of Boswellia Serrata Extract on Acute Inflammatory Parameters and Tumor Necrosis Factor-α in Complete Freund's Adjuvant-Induced Animal Model of Rheumatoid Arthritis
por: Kumar, Rajendra, et al.
Publicado: (2019)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

Effects of tumour necrosis factor-α on BrdU incorporation in cultured human enterocytes
por: McDevitt, J., et al.
Publicado: (1995)

Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study
por: Clunie, Gavin, et al.
Publicado: (2018)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register
por: McWilliams, Daniel F., et al.
Publicado: (2016)

Tumor necrosis factor α-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis
por: Inoue, Asuka, et al.
Publicado: (2009)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
por: Oh, Gyu Man, et al.
Publicado: (2020)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis
por: Goldstein, Richard S
Publicado: (2008)

Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
por: Ji, Hong, et al.
Publicado: (2002)

Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice
por: Moe, K T, et al.
Publicado: (2011)

Inhibitory effect of esculentoside A on tumour necrosis factor α production by human monocytes
por: Wang, H-B., et al.
Publicado: (1996)

Anti‐inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization
por: Assas, B. M., et al.
Publicado: (2016)

Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn’s disease
por: Li, Kangrong, et al.
Publicado: (2023)

Rac1 activation induces tumour necrosis factor-α expression and cardiac dysfunction in endotoxemia
por: Zhang, Ting, et al.
Publicado: (2011)

Overexpression of Tumour Necrosis Factor-α-Induced Protein 8 is Associated with Prognosis in Colon Cancer
por: Zhang, Xingqi, et al.
Publicado: (2021)

Anti‐tumour necrosis factor‐α‐induced lupus in a patient receiving infliximab for sarcoidosis
por: Stranks, Lachlan, et al.
Publicado: (2022)

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2014)

Inhibition of established collagen-induced arthritis with a tumour necrosis factor-α inhibitor expressed from a self-contained doxycycline regulated plasmid
por: Gould, David J, et al.
Publicado: (2004)

Paradoxical Side Effect Related With Anti-Tumor Necrosis Factor Alpha Treatment
por: Aşkın, Ayhan, et al.
Publicado: (2017)

Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment
por: Chokshi, Aditi, et al.
Publicado: (2023)

Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells
por: Oguma, Keisuke, et al.
Publicado: (2008)

Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis
por: Cacciapaglia, Fabio, et al.
Publicado: (2016)

Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells
por: Karlsson, Jessica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gokap1bbjmhpdht0qfivva8cp7